Cloud Services & Network Solutions
The FDA will meet Feb. 26 to discuss what Johnson & Johnson says is a 66% effective, single-dose vaccine for preventing COVID-19. Johnson & Johnson seeks FDA emergency authorization for COVID-19 vaccine – CNET Source: CNet